Podcast # 341: Tenecteplase vs. Alteplase
Jun 13, 2018•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Author: Rachel Beham, PharmD
Educational Pearls:
- Tenecteplase is more specific for fibrin and has a longer half-life than alteplase.
- In setting of ischemic stroke, tenecteplase before thrombectomy was associated with a statistically higher incidence of reperfusion and better functional outcome than alteplase.
References
Bruce C.V. Campbell B et al (2018). Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. New England Journal of Medicine. 378:1573-1582
For the best experience, listen in Metacast app for iOS or Android